Cambridge Investment Research Advisors, Inc. Haleon PLC Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Haleon PLC stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 46,060 shares of HLN stock, worth $426,976. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,060
Previous 51,771
11.03%
Holding current value
$426,976
Previous $533,000
10.32%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding HLN
# of Institutions
704Shares Held
469MCall Options Held
158KPut Options Held
0-
Dodge & Cox San Francisco, CA155MShares$1.44 Billion0.97% of portfolio
-
Clearbridge Investments, LLC New York, NY31.4MShares$292 Million0.28% of portfolio
-
Harding Loevner LP Bridgewater, NJ22.6MShares$209 Million1.62% of portfolio
-
Morgan Stanley New York, NY17.7MShares$164 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA16.7MShares$155 Million0.03% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $42.8B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...